Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.indswift.com | |
Market Cap | 50.86 Cr. | |
Enterprise Value(EV) | 1,081.26 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -6.93 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2022-09 |
Industry PE | 32.22 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | -137.79 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | -0.07 | Calculated using Price: 9.39 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 5.42 Cr. | 54,164,653 Shares |
FaceValue | 2 | |
Company Profile | ||
Ind-Swift Limited was incorporated as a public limited company on June 6, 1986 under the Companies Act 1956.It is the flagship company of India based Ind Swift Group. Ind-Swift Limited is a north India based pharmaceutical company. |
1 Day |
|
-2.85% |
1 Week |
|
-8.96% |
1 Month |
|
-20.48% |
3 Month |
|
+4.14% |
6 Month |
|
-9.65% |
1 Year |
|
-32.13% |
2 Year |
|
+114.61% |
5 Year |
|
+12.88% |
10 Year |
|
-26.71% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | -112.51 | |||||||||
Return on Capital Employed (%) | -4.27 | -10.41 | -20.35 | -56.22 | -10.31 | 3.37 | 5.82 | 7.19 | 11.69 | |
Return on Assets (%) | -8.26 | -11.09 | -17.47 | -42.12 | -8.45 | 1.35 | -3.19 | -4.68 | -3.07 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 108 | -40 | -239 | -611 | -679 | -677 | -713 | -695 | -720 | -746 | |
Non Curr. Liab. | 596 | 549 | 679 | 672 | 694 | 659 | 661 | 661 | 634 | 638 | |
Curr. Liab. | 686 | 718 | 621 | 608 | 598 | 616 | 654 | 706 | 718 | 732 | |
Minority Int. | |||||||||||
Equity & Liab. | 1,390 | 1,228 | 1,061 | 669 | 613 | 598 | 602 | 672 | 632 | 623 | |
Non Curr. Assets | 506 | 469 | 439 | 463 | 427 | 405 | 373 | 406 | 389 | 391 | |
Curr. Assets | 851 | 738 | 612 | 206 | 186 | 194 | 229 | 265 | 242 | 232 | |
Misc. Exp. not W/O | 33 | 21 | 10 | ||||||||
Total Assets | 1,390 | 1,228 | 1,061 | 669 | 613 | 598 | 602 | 672 | 632 | 623 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 570 | 417 | 304 | 263 | 270 | 289 | 330 | 356 | 398 | 408 | |
Other Income | 13 | 2 | 13 | 14 | 15 | 8 | 22 | 15 | 24 | 12 | |
Total Income | 583 | 419 | 317 | 277 | 284 | 297 | 352 | 371 | 421 | 421 | |
Total Expenditure | -604 | -487 | -461 | -328 | -264 | -278 | -306 | -315 | -352 | -370 | |
PBIDT | -21 | -68 | -144 | -52 | 21 | 19 | 46 | 57 | 69 | 50 | |
Interest | -77 | -40 | -19 | -16 | -11 | -4 | -35 | -52 | -57 | -58 | |
Depreciation | -26 | -39 | -36 | -36 | -35 | -34 | -34 | -33 | -32 | -30 | |
Taxation | 9 | 2 | 0 | -1 | -1 | -2 | 0 | 0 | |||
Exceptional Items | -260 | -28 | 27 | 6 | -1 | 1 | 1 | ||||
PAT | -116 | -145 | -200 | -364 | -54 | 8 | -19 | -30 | -20 | -38 | |
Adjusted EPS | -23 | -29 | -40 | -67 | -10 | 2 | -4 | -6 | -4 | -7 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | -146 | 103 | 86 | -106 | 7 | 1 | 43 | 35 | 83 | 90 | |
Cash Fr. Inv. | -28 | -14 | -6 | -4 | -4 | -3 | -14 | -11 | -17 | -18 | |
Cash Fr. Finan. | 146 | -89 | -81 | 110 | -11 | -4 | -13 | -26 | -54 | -84 | |
Net Change | -28 | 0 | -1 | 0 | -8 | -5 | 16 | -3 | 12 | -13 | |
Cash & Cash Eqvt | 18 | 18 | 17 | 17 | 9 | 4 | 20 | 17 | 29 | 16 |
Sat, 28 Jan 2023
Board Meeting Intimation for Consideration And Approval Of Un-Audited Financial Results For Quarter And Nine Months Ended 31St December 2022. IND-SWIFT LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve Pursuant to the provisions of Regulation 29(1)(a) of the Securities & Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations 2015 notice is hereby given that the meeting of Board of Directors of the Company is scheduled to be held on Monday 13th February 2023 inter-alia to consider approve and take on record the Un-audited Financial Results of the Company for the Quarter and nine months ended December 31 2022. |
Tue, 10 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 In compliance with regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 please find enclosed a copy of the certificate dated 7th January 2023 received from Alankit Assignments Limited Registrar and Transfer Agent of the Company for the quarter ended 31st December 2022. You are requested to take the above information in your record. |
Fri, 30 Dec 2022
Closure of Trading Window This is to inform the Exchange that as per the Companys Code of Conduct for prevention of Insider Trading read with Regulation 4 of the Schedule B of SEBI (Prohibition of Insider Trading) Regulations 2015 and notification no. NSE/CML/2019/11 and LIST/COMP/01/2019-20 issued respectively by NSE and BSE on 2nd April 2019 the Trading Window for dealing in Equity Shares of the Company shall remain closed for all Promoters members of the Promoter Group Directors/Officers/Designated Employees covered under the said code from the start of business hours at 9:00 A.M. on 1st January 2023 till 48 hours from the conclusion of the Board Meeting to be held for the purpose of consideration of Un-Audited Financial Results for the quarter ended 31st December 2022. |
Fri, 03 Feb 2023 |
|
|
|
|
|